IP Library Granted Patent US 11,970,739
Granted Patent B2
US 11,970,739 · App. 18/348,063 · Granted Apr 30, 2024

Multiplex capture of gene and protein expression from a biological sample

Inventors: Jennifer Chew (Hayward, CA); Joseph Francis Shuga (Pleasanton, CA); Patrick Roelli (Stockholm, SE); Denise Cheung (Dublin, CA); Alexander Hermes (Livermore, CA); Yifeng Yin (Elk Grove, CA); Naishitha Anaparthy (Dublin, CA); Ryo Hatori (Pleasanton, CA); Marlon Stoeckius (Stockholm, SE); Rapolas Spalinskas (Pleasanton, CA); Anna-Maria Katsori (Stockholm, SE); Cedric Uytingco (Milpitas, CA); Mesruh Turkekul (Stockholm, SE); David Sukovich (Oakland, CA); Christina Galonska (Stockholm, SE); Aleksandra Jurek (Pleasanton, CA); Octavian Marian Bloju (Stockholm, SE)
Assignee: 10x Genomics, Inc.
C12Q1/6874C12N15/1065C12Q1/6837
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,970,739
App. No.
18/348,063
Granted
Apr 30, 2024
Kind
B2
Abstract

Provided herein are methods, compositions, and kits for preparing biological samples for multiplex spatial gene expression and proteomic analysis, such as determining a location of a nucleic acid analyte and a protein analyte in a biological sample.

Claims (25)

1. A composition comprising:

a) a spatial array comprising a substrate comprising:

(i) a first plurality of capture probes wherein the first plurality of capture probes comprise a spatial barcode and a first plurality of capture domains; and

(ii) a second plurality of capture probes wherein the second plurality of capture probes comprise a spatial barcode and a second plurality of capture domains hybridized to a plurality of oligonucleotides from an analyte capture agent, wherein the analyte capture agent comprises an analyte-binding moiety comprising an antibody or an antigen-binding fragment thereof, and wherein the oligonucleotides comprise an analyte capture sequence and an analyte binding moiety barcode; and

b) a pair of probes comprising:

(i) a plurality of first probes, wherein a first probe of the plurality of first probes is hybridized to a target nucleic acid and

(ii) a plurality of second probes, wherein a second probe of the plurality of second probes is hybridized to the target nucleic acid at a separate location from the first probe and wherein the second probe has a sequence complementary to the first plurality of capture domains.

2. The composition of claim 1 , wherein the first plurality of capture probes further comprise one or more functional domains, a cleavage domain, a unique molecular identifier, and combinations thereof.

3. The composition of claim 1 , wherein the second plurality of capture probes further comprise one or more functional domains, a cleavage domain, a unique molecular identifier, and combinations thereof.

4. The composition of claim 1 , wherein the first plurality of capture domains comprise homopolymeric sequences and the second plurality of capture domains comprise homopolymeric sequences.

5. The composition of claim 1 , wherein the first plurality of capture domains are homopolymeric sequences and the second plurality of capture domains are non-homopolymeric sequences.

6. The composition of claim 1 , wherein the first plurality of capture domains are non-homopolymeric sequences and the second plurality of capture domains are non-homopolymeric sequences.

7. The composition of claim 4 , wherein the first plurality of capture domains and the second plurality of capture domains are poly(T) sequences.

8. The composition of claim 6 , wherein the non-homopolymeric sequences of the first plurality of capture domains and the non-homopolymeric sequences of the second plurality of capture domains are different.

9. The composition of claim 5 , wherein the homopolymeric sequences of the first plurality of capture domains are poly(T) sequences and the non-homopolymeric sequences of the second plurality of capture domains comprise a fixed sequence.

10. The composition of claim 9 , wherein the fixed sequence comprises at least one sequence selected from SEQ ID NO: 1 through SEQ ID NO: 11.

11. The composition of claim 1 , wherein the spatial array further comprises one or more protein dilution series.

12. The composition of claim 1 , wherein the spatial array comprising the substrate comprises a plurality of features, wherein a feature of the plurality of features comprises a bead or a well.

13. The composition of claim 12 , wherein the first plurality of capture probes and the second plurality of capture probes are directly attached to the substrate.

14. The composition of claim 12 , wherein the first plurality of capture probes and the second plurality of capture probes are indirectly attached to the substrate.

15. The composition of claim 1 , wherein the target nucleic acid is DNA.

16. The composition of claim 1 , wherein the target nucleic acid is RNA.

17. The composition of claim 1 , further comprising a RNase.

18. The composition of claim 1 , further comprising a permeabilization reagent.

19. The composition of claim 18 , wherein the permeabilization reagent comprises a protease and a detergent.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2023
From: CHEW, JENNIFER; SHUGA, JOSEPH FRANCIS; CHEUNG, DENISE; HERMES, ALEXANDER; YIN, YIFENG; ANAPARTHY, NAISHITHA; HATORI, RYO; UYTINGCO, CEDRIC; SUKOVICH, DAVID
To: 10X GENOMICS, INC.
Reel/Frame 064480/0558 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2023
From: ROELLI, PATRICK; STOECKIUS, MARLON; SPALINSKAS, RAPOLAS; KATSORI, ANNA-MARIA; TURKEKUL, MESRUH; GALONSKA, CHRISTINA; JUREK, ALEKSANDRA; BLOJU, OCTAVIAN MARIAN
To: SPATIAL TRANSCRIPTOMICS AB
Reel/Frame 064480/0601 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2023
From: SPATIAL TRANSCRIPTOMICS AB
To: 10X GENOMICS, INC.
Reel/Frame 064480/0647 →
Continuity (9)
Continuation 17867223 · Jul 18, 2022
Continuation PCTUS2022020985 · Mar 18, 2022
Provisional Application 63311703 · Feb 18, 2022
Provisional Application 63270230 · Oct 21, 2021
Provisional Application 63252335 · Oct 5, 2021
Provisional Application 63245697 · Sep 17, 2021
Provisional Application 63214058 · Jun 23, 2021
Provisional Application 63162870 · Mar 18, 2021
Related Publication 20240011090A1 · Jan 11, 2024
Cited By (42)
US 12,195,790 US 12,203,134 US 12,209,280 US 12,223,751 US 12,228,544 US 12,234,505 US 12,241,060 US 12,241,890 US 12,249,085 US 12,265,079 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,297,487 US 12,297,488 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,385,083 US 12,391,979 US 12,391,980 US 12,399,123 US 12,405,264 US 12,416,603 US 12,435,363 US 12,442,045 US 12,497,654 US 12,508,590 US 12,545,949 US 12,553,805 US 12,553,898 US 12,566,113 US 12,566,114 US 12,571,029 US 12,624,475 US 12,637,706 US 12,692,492